Operating

Change in AP

West Pharmaceutical Services Change in AP remained flat by 0.0% to $4.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 517.2%, from $725.00K to $4.48M. Over 4 years (FY 2021 to FY 2025), Change in AP shows relatively stable performance with a 1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

An increase is generally positive for cash flow, as it allows the company to retain cash longer, provided it does not damage supplier relationships.

Detailed definition

This measures the change in the amount the company owes to its suppliers and vendors for goods and services received. An...

Peer comparison

Standard metric; companies often aim to optimize payment terms to maximize cash availability.

Metric ID: change_in_accounts_payable

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$16.80M-$2.80M$4.40M$2.90M$17.90M
YoY Change-116.7%+257.1%-34.1%+517.2%
Range-$2.80M$17.90M
CAGR+1.6%
Avg YoY Growth+155.9%
Median YoY Growth+111.5%

Frequently Asked Questions

What is West Pharmaceutical Services's change in ap?
West Pharmaceutical Services (WST) reported change in ap of $4.48M in Q4 2025.
How has West Pharmaceutical Services's change in ap changed year-over-year?
West Pharmaceutical Services's change in ap increased by 517.2% year-over-year, from $725.00K to $4.48M.
What is the long-term trend for West Pharmaceutical Services's change in ap?
Over 4 years (2021 to 2025), West Pharmaceutical Services's change in ap has grown at a 1.6% compound annual growth rate (CAGR), from $16.80M to $17.90M.
What does change in ap mean?
The change in money the company owes to its suppliers.